Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
Leukotrienes are important pro-inflammatory lipid mediators derived from the arachidonic acid metabolism. In particular, cysteinyl leukotrienes, namely LTC4, LTD4, and LTE4 are involved in many of the principal features of asthma, while more recently they have also been implicated in cardiovascular...
Saved in:
Main Authors: | Marina Camera (Author), Paola Canzano (Author), Marta Brambilla (Author), G. Enrico Rovati (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Montelukast Use Decreases Cardiovascular Events in Asthmatics
by: Malvina Hoxha, et al.
Published: (2021) -
Montelukast does not inhibit the late phase reaction in parthenium dermatitis
by: Chembolli Lakshmi, et al.
Published: (2009) -
The Benefit of Montelukast in Atopic Dermatitis Induced by Food Allergies
by: Isaac Melamed, et al.
Published: (2017) -
Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence
by: Jean Barré, et al.
Published: (2020) -
Investigation of montelukast effect on rosuvastatin induced late puberty in rats
by: Tamadir Hamid Wadi Aledani, et al.
Published: (2022)